<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lerner S</submitter><funding>NICHD NIH HHS</funding><funding>European Research Council</funding><funding>Medical Research Council</funding><pagination>1471-1485</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8460544</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>140(10)</volume><pubmed_abstract>Argininosuccinate lyase (ASL) is essential for the NO-dependent regulation of tyrosine hydroxylase (TH) and thus for catecholamine production. Using a conditional mouse model with loss of ASL in catecholamine neurons, we demonstrate that ASL is expressed in dopaminergic neurons in the substantia nigra pars compacta, including the ALDH1A1&lt;sup> +&lt;/sup> subpopulation that is pivotal for the pathogenesis of Parkinson disease (PD). Neuronal loss of ASL results in catecholamine deficiency, in accumulation and formation of tyrosine aggregates, in elevation of α-synuclein, and phenotypically in motor and cognitive deficits. NO supplementation rescues the formation of aggregates as well as the motor deficiencies. Our data point to a potential metabolic link between accumulations of tyrosine and see</pubmed_abstract><journal>Human genetics</journal><pubmed_title>ASL expression in ALDH1A1&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; neurons in the substantia nigra metabolically contributes to neurodegenerative phenotype.</pubmed_title><pmcid>PMC8460544</pmcid><funding_grant_id>818943</funding_grant_id><funding_grant_id>MR/T008024/1</funding_grant_id><funding_grant_id>U54 HD061221</funding_grant_id><pubmed_authors>Balmat TJ</pubmed_authors><pubmed_authors>Harding CO</pubmed_authors><pubmed_authors>Lerner S</pubmed_authors><pubmed_authors>Mazkereth R</pubmed_authors><pubmed_authors>Ruiz SG</pubmed_authors><pubmed_authors>Schulze A</pubmed_authors><pubmed_authors>Seminara J</pubmed_authors><pubmed_authors>McCarter R</pubmed_authors><pubmed_authors>Ryten M</pubmed_authors><pubmed_authors>Stricker T</pubmed_authors><pubmed_authors>Gallagher RC</pubmed_authors><pubmed_authors>Tuchman M</pubmed_authors><pubmed_authors>Weisfeld-Adams JD</pubmed_authors><pubmed_authors>Wong D</pubmed_authors><pubmed_authors>Kreiser T</pubmed_authors><pubmed_authors>Berry SA</pubmed_authors><pubmed_authors>Bedoyan JK</pubmed_authors><pubmed_authors>Izem R</pubmed_authors><pubmed_authors>Erez A</pubmed_authors><pubmed_authors>Adler L</pubmed_authors><pubmed_authors>Gazit E</pubmed_authors><pubmed_authors>Eilam R</pubmed_authors><pubmed_authors>Waisbren S</pubmed_authors><pubmed_authors>Coughlin C</pubmed_authors><pubmed_authors>McCandless SE</pubmed_authors><pubmed_authors>Spada M</pubmed_authors><pubmed_authors>Garcia AC</pubmed_authors><pubmed_authors>Ranucci G</pubmed_authors><pubmed_authors>Baumgartner MR</pubmed_authors><pubmed_authors>Berry G</pubmed_authors><pubmed_authors>Gropman A</pubmed_authors><pubmed_authors>Hoffmann G</pubmed_authors><pubmed_authors>Members of the UCDC</pubmed_authors><pubmed_authors>Dionisi-Vici C</pubmed_authors><pubmed_authors>Nagamani SCS</pubmed_authors><pubmed_authors>Enns G</pubmed_authors><pubmed_authors>Le Mons C</pubmed_authors><pubmed_authors>Merritt JL</pubmed_authors><pubmed_authors>Richesson R</pubmed_authors><pubmed_authors>Tsoory M</pubmed_authors><pubmed_authors>Burgard P</pubmed_authors><pubmed_authors>Baruteau J</pubmed_authors><pubmed_authors>Brandis A</pubmed_authors><pubmed_authors>Burrage L</pubmed_authors><pubmed_authors>Yudkoff M</pubmed_authors><pubmed_authors>Mehlman T</pubmed_authors><pubmed_authors>Botia JA</pubmed_authors><pubmed_authors>Diaz GA</pubmed_authors></additional><is_claimable>false</is_claimable><name>ASL expression in ALDH1A1&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; neurons in the substantia nigra metabolically contributes to neurodegenerative phenotype.</name><description>Argininosuccinate lyase (ASL) is essential for the NO-dependent regulation of tyrosine hydroxylase (TH) and thus for catecholamine production. Using a conditional mouse model with loss of ASL in catecholamine neurons, we demonstrate that ASL is expressed in dopaminergic neurons in the substantia nigra pars compacta, including the ALDH1A1&lt;sup> +&lt;/sup> subpopulation that is pivotal for the pathogenesis of Parkinson disease (PD). Neuronal loss of ASL results in catecholamine deficiency, in accumulation and formation of tyrosine aggregates, in elevation of α-synuclein, and phenotypically in motor and cognitive deficits. NO supplementation rescues the formation of aggregates as well as the motor deficiencies. Our data point to a potential metabolic link between accumulations of tyrosine and see</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2026-04-08T07:29:58.255Z</modification><creation>2022-02-11T11:55:11.483Z</creation></dates><accession>S-EPMC8460544</accession><cross_references><pubmed>34417872</pubmed><doi>10.1007/s00439-021-02345-5</doi></cross_references></HashMap>